Molecular Partners
Philippe Legenne, M.D., serves as Chief Medical Officer of Molecular Partners since September 2024 and prior as acting Chief Medical Officer from September 2023 to August 2024.
Basic Information
- Category: biotechnology
- Website: http://www.molecularpartners.com/
Documented Facts
- Email: info@molecularpartners.com (No linked source recorded for this statement.)
- CEO: of Molecular Partners (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: V8 (No linked source recorded for this statement.)
- Stock ticker: MOLN (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Molecular Partners — Official Site (official)
- Molecular Partners on linkedin (social)
- MOLECULAR PARTNERS AG — SEC EDGAR (reference)
Citation Guidance
Explore biotechnology profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Molecular Partners.
- Canonical profile: https://brandsource.ai/brands/molecular-partners
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/molecular-partners/json-ld
- Citation profile API: https://brandsource.ai/api/brands/molecular-partners/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Philippe Legenne, M.D., serves as Chief Medical Officer of Molecular Partners since September 2024 and prior as acting Chief Medical Officer from September 2023 to August 2024.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 5 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.